Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/37122| Title: | Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. | |
| Authors: | ||
| Issue Date: | 1-Jul-2018 | |
| Citation: | J. Antimicrob. Chemother..2018 Jul;(73)7:1940-1948 | |
| Abstract: | Monotherapy with ritonavir-boosted PIs (PI/r) has been used to simplify treatment of HIV-1-infected patients. In previous studies raltegravir intensification evidenced ongoing viral replication and reduced T cell activation, preferentially in subjects receiving PI-based triple ART. However, data about low-level viral replication and its consequences in patients receiving PI/r monotherapy are scarce. | |
| PMID: | 29635527 | |
| URI: | https://hdl.handle.net/20.500.12530/37122 | |
| Rights: | openAccess | |
| Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PMC6005067.pdf | 653.86 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.